ALBRECHT DETLEF (Chief Medical Officer) sold 1.0% of their position (200.00 shares) of SATSUMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $4.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2020ACC: 0001567619-20-007501
Officer· Chief Medical Officer
Since Sep 2019
-200.00
Net shares
Net seller
$4.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
200.00 acquired · 400.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+200.00
Price / share
$4.56
Trade value
$912.00
% of position
1.0%
4/1/2020
20.21K→20.41K
Common Stock
Direct
Shares
−200.00
Price / share
$20.25
Trade value
$4.05K
% of position
1.0%
4/1/2020
20.21K→20.01K
Total
Net shares
+0.00
Net value
-$3.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2020 | M · Option Exercise | +200.00 | $4.56 | $912.00 | 1.0% | 20.21K | 20.41K |
| Common Stock Direct | 4/1/2020 | S · Sale | −200.00 | $20.25 | $4.05K | 1.0% | 20.21K | 20.01K |
| Total | +0.00 | -$3.14K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
200.00 shares
Shares
−200.00
Strike price
4.56
Held after
73.27K
Exercisable
—
4/1/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock200.00 shares | 4/1/2020 | S · Sale | −200.00 | 4.56 | — | 73.27K |